Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke

Tudor G. Jovin et al. · PI Antoni Dávalos, MD

Primary endpoint

Between-group comparison of the distribution of the modified Rankin Scale scores (shift analysis)

Population

Acute Stroke; n=206

doi:10.1056/NEJMoa1503780

Historical

Current

Future

3 noemes

Historical

1 noeme

Published findings from this trial. Vote whether the expert body still believes each noeme stands given current evidence.

The REVASCAT trial's stated primary conclusion — Thrombectomy up to 8h after stroke onset is superior to medical therapy in selected patients. — replicates in independent cohorts.

neurointerventional

Current

1 noeme

Noemes tracking active replication, subgroup analysis, or long-term follow-up. Vote on the likelihood the original effect holds.

Recent follow-up analyses of REVASCAT are confirming the original effect size in real-world data.

neurointerventional

Future

1 noeme

Open forecast horizons tied to this trial. Vote your probability that each resolves TRUE by the declared horizon.

By 2028, outcomes observed in the REVASCAT 8h arm will replicate in at least three independent national registries.

neurointerventional

71%

Semantically related trials

Nearest trials by noeme-centroid cosine distance. Lower = closer.

NCT01804355

0.1216

· 3 claims

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

NCT02586415

0.1463

· 3 claims

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging

NCT01778335

0.1468

· 3 claims

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

NCT02142283

0.1539

· 3 claims

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct

NCT01492725

0.1610

· 3 claims

Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection

NCT01657461

0.1700

· 3 claims

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke